Acute neuroendocrine response to sexual stimulation in sexual offenders

Canadian Journal of Psychiatry

Volumn 48, Issue 4, 2003, Pages 265-271

  Haake, Philip ^a   Schedlowski, Manfred ^a   Exton, Michael S ^a   Giepen, Christoph ^a   Hartmann, Uwe ^b   Osterheider, Michael ^c   Flesch, Martin ^c   Janssen, Onno E ^a   Leygraf, Norbert ^a   Krüger, Tillmann H C ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c Westfalian Ctr Forensic Psychiat   (Germany)

Author keywords

Endocrinology; Forensic; Prolactin; Regulation; Sexual drive; Sexual offenders

Indexed keywords

PROLACTIN;

ADULT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; FEEDBACK SYSTEM; GERMANY; HEART RATE; HUMAN; HUMAN EXPERIMENT; INTERVIEW; LIBIDO; MAJOR CLINICAL STUDY; MALE; MASTURBATION; NEUROENDOCRINOLOGY; NORMAL HUMAN; OFFENDER; ORGASM; PROLACTIN BLOOD LEVEL; SEXUAL AROUSAL; SEXUAL CRIME; STATISTICAL ANALYSIS; VOLUNTEER;

EID: 0038070247     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370304800411     Document Type: Article

References (41)

1. Meston CM, Frohlich PF. The neurobiology of sexual function. Arch Gen Psychiatry 2000;57:1012-30.
2. Bowers MB, Woert MV, Davis L. Sexual behaviour during L-DOPA treatment for parkinsonism. Am J Psychiatry 1971;127:1691-3.
3. Uitti RJ, Tanner CM, Rajput AH, Goetz CG, Klawans HL, Thiessen B. Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol 1989;12:375-83.
4. Wass JAH, Thomer MO, Morris DV, Rees LH, Stuart-Mason A, Jones AE, and others. Long term treatment of acromegaly with bromocriptine. BMJ 1977;1:875-8.
5. Dula E, Bukofzer S, Perdok R, George M. Double-blind, crossover comparison of 3 mg apomorphine SL with placebo and with 4 mg apomorphine SL in male dysfunction. Eur Urol 2001;39:558-64.
6. Paice JA, Penn RD, Ryan WG. Altered sexual function and decreased testosterone in patients receiving intraspinal opioids. J Pain Symptom Manage 1994;9:126-31.
7. Alexander GM, Sherwin BB. The association between testosterone, sexual arousal, and selective attention for erotic stimuli in men. Horm Behav 1991;25:367-81.
8. Lange JD, Brown WA, Wincze JP, Zwick W. Serum testosterone concentration and penile tumescence changes in men. Horm Behav 1980;14:267-70.
9. Mantzoros CS, Georgiadis EI, Trichopoulos D. Contribution of dihydrotestosterone to male sexual behavior. BMJ 1995;310:1289-91.
10. Andersson RA, Bancroft J, Wu FCW. The effects of exogenous testosterone on sexuality and mood of normal men. J Clin Endocrinol Metab 1992;75:1503-7.
11. Tuiten A, Van Honk J, Koppeschaar H, Bemaards C, Thijssen J, Verbaten R. Time course of effects of testosterone administration on sexual arousal in women. Arch Gen Psychiatry 2000;57:149-53.
12. Bradford JMW. Treatment of men with paraphilia. New Engl J Med 1998;338:464-5.
13. Bradford JMW, Boulet J, Pawlak A. The paraphilias: a multiplicity of deviant behaviours. Can J Psychiatry 1992;37:104-8.
14. Banks T, Dabbs JM. Salivary testosterone and cortisol in a delinquent and violent urban subculture. J Soc Psychol 1996;136:49-56.
15. Dabbs JM, Hargrove MF. Age, testosterone, and behaviour among female prison inmates. Psychosom Med 1997;59:477-80.
16. Rada RT, Laws DR, Kellner R. Plasma testosterone levels in the rapist. Psychosom Med 1976;38:257-68.
17. Bradford JMW, McLean D. Sexual offenders, violence and testosterone: a clinical study. Can J Psychiatry 1984;29:335-43.
18. Bradford JMW, Pawla A. Effects of cyproterone acetate on sexual arousal patterns ofpedophiles. Arch Sex Behav 1993;22:629-41.
19. Bradford JMW. Organic treatment for the male sexual offender. Ann NY Acad Sci 1988;528:193-202.
20. Gagne P. Treatment of sex offenders with medroxyprogesterone acetate. Am J Psychiatry 1981;138:644-6.
21. Cooper AJ. A placebo-controlled trial of the antiandrogen cyproterone acetate in deviant hypersexuality. Compr Psychiatry 1981;22:458-65.
22. Dickey R. The management of a case of treatment-resistant paraphilia with long-acting LHRH agonists. Can J Psychiatry 1992;37:567-9.
23. Thibaut F, Cordier B, Kuhn J-M. Gonadotrophin hormone releasing hormone agonist in cases of severe paraphilia: a lifetime treatment. Psychoneuroendocrinology 1996;21:411-9.
24. Rösler A, Witztum E. Treatment of men with paraphilia with a long-acting analogue of gonadotropin-releasing hormone. New Engl J Med 1998;338:416-22.
25. Krüger T, Exton MS, Pawlak C, von zur Mühlen A, Hartmann U, Schedlowski M. Neuroendocrine and cardiovascular response to sexual arousal and orgasm in men. Psychneuroendocrinology 1998;23:401-11.
26. Exton MS, Bindert A, Krüger T, Scheller F, Hartmann U, Schedlowski M. Cardiovascular and endocrine alterations after masturbation-induced orgasm in women. Psychosom Med 1999;61:280-9.
27. Exton NG, Truong TC, Exton MS, Wingenfeld SA, Leygraf N, Saller B, and others. Neuroendocrine response to film-induced sexual arousal in men and women. Psychoneuroendocrinology 2000;25:187-99.
28. Exton MS, Krüger THC, Koch M, Paulson E, Knapp W, Hartmann U, and others. Coitus-induced orgasm stimulates prolactin secretion in healthy subjects. Psychoneuroendocrinology 2001;26:287-94.
29. Exton MS, Krüger THC, Bursch N, Knapp W, Haake P, Schedlowski M, and others. Neuroendocrine response to masturbation-induced orgasm following a 3-week sexual abstinence. World J Urol 2001;19:377-82.
30. Haake P, Exton MS, Haverkamp J, Krämer M, Leygraf N, Hartmann U, and others. Absence of orgasm-induced prolactin secretion in a healthy multi-orgasmic male subject. Int J Impot Res 2002;14:133-5.
31. Buvat J, Lemaire A, Buvat-Herbaut M, Fourlinnie JC, Racadot A, Fossati P. Hyperprolactinemia and sexual function in men. Horm Res 1985;22:196-203.
32. Sobrinho LG. The psychogenic effects of prolactin. Acta Endocrinol 1993;129:38-40.
33. Krüger THC, Haake P, Hartmann U, Schedlowski M, Exton MS. Prolactin release following orgasm: a feedback control of sexual arousal? Neurosci Biobehav Rev 2002;26:31-44.
34. Kohler T, Boelicke T. Do patients with rheumatoid arthritis suppress anger and aggression? Psychother Psychosom Med Psychol 2000;50:157-60.
35. Deegener G. Multiphasic Sex Inventory: (MSI); Fragebogen zur Erfassung psychosexueller Merkmale bei Sexualstraftätern. Handbuch. Göttingen, Bem, Toronto, Seattle: Hogrefe; 1996.
36. Bradford JMW. The neurobiology, neuropharmacology, and pharmacological treatment ofparaphilias and compulsive sexual behaviour. Can J Psychiatry 2001;46:26-34.
37. Grossmann LS, Martis B, Fichtner CG. Are sex offenders treatable? A research overview. Psychiatr Serv 1999;50:349-61.
38. Kafka MP, Prentky R. Fluoxetine treatment of non-paraphilic sexual addictions and paraphilias in men. J Clin Psychiatry 1992;53:351-8.
39. Kafka MP. Sertraline pharmacotherapy for paraphilias and paraphilia-related disorders: an open trial. Ann Clin Psychiatry 1994;6:189-95.
40. Greenberg DM, Bradford JMW, Curry S, O'Rourke A. A comparison of treatment of paraphilias with three serotonin reuptake inhibitors: a retrospective study. Bull Am Acad Psychiatry Law 1996;24:525-32.
41. Stein DJ, Hollander E, Anthony DT, Schneider FR, Fallon BA, Liebowitz MR. Serotonergic medications for sexual obsessions, sexual addictions and paraphilias. J Clin Psychiatry 1992;53:267-71.